SNTI icon

Senti Biosciences
SNTI

Overview Fund Activity

27 hedge funds and large institutions have $4.15M invested in Senti Biosciences in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+2
Holders Change %
+8%
% of All Funds
0.39%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
3
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Two Sigma Investments
1
Two Sigma Investments
New York
$35.3K
2
Citadel Advisors
2
Citadel Advisors
Florida
$29.8K
3
Renaissance Technologies
3
Renaissance Technologies
New York
$9K
4
VF
4
Virtu Financial
New York
$7K
5
TRCT
5
Tower Research Capital (TRC)
New York
$3.21K

Top Sellers

1
OFM
1
Omega Fund Management
Massachusetts
$0
2
AIM
2
ARK Investment Management
Florida
$615K
3
AG
3
Artal Group
Luxembourg
$0
4
XT
4
XTX Topco
Cayman Islands
$0
5
Bank of New York Mellon
5
Bank of New York Mellon
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Comerica Bank
26
Comerica Bank
Texas
$18 – – –
Toronto Dominion Bank
27
Toronto Dominion Bank
Ontario, Canada
$14 +$14 +4 New
OFM
28
Omega Fund Management
Massachusetts
– -$129K -19,579 Closed
AG
29
Artal Group
Luxembourg
– -$37K -5,556 Closed
XT
30
XTX Topco
Cayman Islands
– -$14.3K -2,165 Closed
Bank of New York Mellon
31
Bank of New York Mellon
New York
– -$8.16K -1,237 Closed
JPMorgan Chase & Co
32
JPMorgan Chase & Co
New York
– -$28 -4 Closed
1
2